Palvella Therapeutics Inc...

NASDAQ: PVLA · Real-Time Price · USD
47.12
1.02 (2.21%)
At close: Aug 15, 2025, 3:59 PM
48.00
1.88%
After-hours: Aug 15, 2025, 05:20 PM EDT

Palvella Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q1 2024 Q4 2023 Q3 2023 Q1 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Mar 31, 2023
Net Income
-15.12M -8.19M -2.54M -4.58M -10.75M -6.71M
Depreciation & Amortization
n/a n/a n/a n/a 739K n/a
Stock-Based Compensation
2.38M 1.09M 146K n/a n/a 141K
Other Working Capital
-340K -2.45M 340K -14.34M -15.52M -550K
Other Non-Cash Items
2.06M 1.29M 863K -748K 15.81M 2.66M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-425K -967K 425K -14.34M -15.52M -47K
Operating Cash Flow
-11.1M -6.77M -1.1M -19.67M -9.72M -3.95M
Capital Expenditures
n/a n/a n/a 13K -69K n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -7.57M -7.03M n/a
Sales Maturities Of Investments
n/a n/a n/a 11M 5.11M n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a 3.45M -1.98M n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-853K -1.27M n/a n/a n/a n/a
Financial Cash Flow
-853K -1.2M n/a 14K n/a n/a
Net Cash Flow
64.19M -7.98M -1.1M -15.5M -12.04M -3.95M
Free Cash Flow
-11.1M -6.77M -1.1M -19.66M -9.79M -3.95M